Counterpoint Mutual Funds’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,198
Closed -$480K 306
2024
Q4
$480K Buy
+5,198
New +$407K 0.06% 120
2024
Q3
Sell
-4,288
Closed -$246K 306
2024
Q2
$246K Buy
+4,288
New +$216K 0.06% 123
2023
Q4
Sell
-11,642
Closed -$285K 143
2023
Q3
$285K Buy
+11,642
New +$238K 0.24% 6
2023
Q2
Sell
-8,415
Closed -$109K 328
2023
Q1
$109K Sell
8,415
-5,139
-38% -$65.7K 0.1% 192
2022
Q4
$153K Buy
+13,554
New +$142K 0.16% 70
2022
Q3
Sell
-24,118
Closed -$234K 260
2022
Q2
$234K Buy
24,118
+16,850
+232% +$181K 0.16% 25
2022
Q1
$87K Buy
+7,268
New +$85.7K 0.07% 43
2021
Q3
Sell
-1,634
Closed -$13K 180
2021
Q2
$13K Buy
+1,634
New +$13.6K 0.01% 50

Other funds holding CLS

Counterpoint Mutual Funds's CLS Position: Q1 2025 in Review

Counterpoint Mutual Funds sold out of Celestica (CLS) in Q1 2025, closing a stake of 5,198 shares — an estimated $480K sold.

Counterpoint Mutual Funds first reported a position in CLS in Q2 2021 and held it in 8 quarters. The position peaked at $480K in Q4 2024. 491 funds tracked by Wall St. Rank hold CLS as of Q1 2025.

  • Counterpoint Mutual Funds reported no remaining Celestica position as of Q1 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 5,198 Celestica shares in Q1 2025, an estimated $480K.
  • Counterpoint Mutual Funds first reported a position in Celestica in Q2 2021 and held it in 8 quarters.
  • Counterpoint Mutual Funds's Celestica position peaked at $480K in Q4 2024.
  • 491 funds tracked by Wall St. Rank held Celestica as of Q1 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2025, filed 12 Feb 2026.